Mobile drug dependency unit user profile in southeast Spain

Authors

  • Consuelo Egea Zapata Médico. Unidad Móvil de Drogodependencias. Murcia.
  • Mª Dolores Pérez Cárceles Médico. Área de Medicina Legal y Forense. Universidad de Murcia. Enviar correspondencia a: Mª Dolores Pérez Cárceles. Facultad de Medicina. Area de Medicina Legal y Forense. Universidad de Murcia. Campus de Espinardo. 30100 Murcia. Telf: 968/36 7018. Fax: 968/36 4150.
  • Eduardo Osuna Carrillo de Albornoz Médico. Área de Medicina Legal y Forense. Universidad de Murcia.
  • María Falcón Romero Farmacéutica. Área de Medicina Legal y Forense. Universidad de Murcia.
  • Aurelio Luna Maldonado Médico. Área de Medicina Legal y Forense. Universidad de Murcia.

DOI:

https://doi.org/10.20882/adicciones.361

Keywords:

methadone, substance abuse, mobile unit

Abstract

Introduction. Metadone maintenance programmes are about harm reduction, as understood by a series of measures destined to improve the health and quality of life of those who do not want or who cannot give up their addiction. The aim of this paper is to describe the profile of heroin addict when they first sought treatment in a Mobile Drug dependency Unit (MDU), and their acceptance of the unit. Material and methods. Questionnaire-based, descriptive, transversal study of 135 subjects selected in a stratified random way from subjects seeking treatment for the first time in an MDU in Murcia (SE Spain). Details of socio-demographic characteristics, family, personal, consumption, and attendance at therapeutic programmes, clinics and the mobile unit itself were included. Results. The users were mostly young men with a mean age of 26.2 ± 4.6 years. The average school leaving age was 14.4 ± 2.3 years, and 74.1% had been detained previously by the police. The proportion of daily consumption among users for heroin, cocaine, benzodiacepines, cannabis, alcohol and tobacco was 100%, 64%, 18%, 19%, 58%, and 98%, respectively. 37.8% subjects had not received treatment previously. More than a third of users had no knowledge of their serological state. In 90% of cases, the person suggesting that the interviewed subject attended the MDU had himself used the service and continued doing so. Conclusion. The profile of the population seeking advice is defined by their low socio-cultural status, social alienation and early use of alcohol, tobacco and cannabis. The MDU was able to establish contact with a group from the drug-dependent population which had not been motivated to seek treatment before and which would normally shy away from other social services. The influence of partners on beginning treatment was high.

References

Brugal MT, Barrio G, Royuela L, Bravo MJ, de la Fuente L, Regidor E. Estimación de la mortalidad atribuible al consumo de drogas ilegales en España. Med Clin (Barc) 2004; 123:775-7.

Aceijas C, Stimson GV, Hickman M, Rhodes T; United nations Reefernce Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004;

:2295-303.

Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill ON. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS 2005; 19:1207-1214.

Ward J, Hall W, mattick RP. Role of maintenance treatment in opiod dependence. Lancet 1999; 353:221-6.

Rounsaville BJ, Kosten TR. Treatment for opioid dependence: quality and access. JAMA 2000; 283:1337-9.

Ward J, Mattick RP, Hall W. The efectiveness of methadone maintenance treatment: an overview. Drug and Alcohol Review 1994; 13:327-36.

Hernández-Aguado I, Bolumar F. Determinants of HIV infection in intravenous drug users in Valencia, Spain, 1987-1991. Int J Epidemiol 1993; 22:537-42.

Kang SY, Delon G. Correlates of drug injection behaviors among methadone outpatients. Am J Drug Alcohol Abuse 1993; 19:107-18.

Torrens M, San L, Martínez A, Castillo C, Domingo-Salvany A, Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1992; 92:707-16.

Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 2004; 39:1353-68.

Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, McLellan AT. The early course of change in methadone maintenance. Addiction 1998; 1:41-9.

Lee SS, Hollinrake JB, Ng MH. Changing behavioural pattern of drug users in Hong-Kong 1991-1995. Addiction 1998; 93:541-48.

Domingo-Salvany A, Perez K, Torrens M, Bravo MJ, Anto JM, Alonso J. Methadone treatment in Spain, 1994. Drug Alcohol Depend 1999; 56:61-6.

Perez-Gonzalez K, Domingo-Salvany A, Hartnoll R. The characteristics of opiate users seen in an emergency service. Gac Sanit 1999; 13:88-95.

World Health Organization. Programme on substance abuse. An international comparative study of HIV prevalence and risk behavior among drug injectors in 13 cities. Bull Narc 1993; 45:19-46.

Osuna E, Luna A. Behavior at school and social maladjustment. J Forensic Sci 1989; 34:1228-34.

Kaye S, Darke S, Finlay JR. The onset of heroin use and criminal behaviour: does order make a difference? Drug Alcohol Depen 1998; 53:79-86.

Morentin B, Callado LF, Meana JJ. Differences in criminal activity between heroin abusers and subjects without psychiatric disorders-analysis of 578 detainees in Bilbao, Spain. J Forensic Sci 1998; 43:993-9.

Bravo Portela MJ, Barrio Anta G, de la Fuente de Hoz L, Royuela Morales L, Colomo Gómez C, Rodríguez Arenas A. Evolution of the prevalence of HIV infection and risk behavior of drug injection among intravenous drug users infected or not infected by HIV in 3 Spanish cities. Working group of Physicians of the World for the monitoring of HIV infection and risk behaviors in intravenous drug users. Rev Clin Esp 2000; 200:355-9.

Gossop M, Marsden J, Stewart D, Treacy S. Reduced infection risk and sexual risk behaviours after drug misuse treatment: results from the National Tretament Outcome Research Study. AIDS Care 2002; 14:77-93.

Teira R, Suarez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, et al.. Patrón epidemiológico de la infección por el VIH en 15 hospitales españoles: casos de nuevo diagnóstico incluidos en la cohorte VACH en 2001 y 2002. Enferm Infecc Microbiol Clin 2005; 23:213-7.

Ruz Franzi I, Gonzalez-Saiz F, Ruiz Avila F. Drug dependent patients in the methadone maintenance program: evaluation in primary care of psychosocial and organic severity. Aten Primaria 1998; 21:384-8.

Backmund M, Schutz CG, Meyer K, Eichenlaub D, Soyka M. Alcohol consumption heroin users, methadonesubstituted and codeine-substituted patientesfrecuency and correlates use. Eur Addiction Res 2003; 9:45-50.

Pereiro C, Pedreira JD, Castro A. Consumo de drogas e infección VIH/SIDA en individuos de etnia gitana. Salud y Comunidad gitana 1997; 1:14-6.

Jiménez Lerma JM, Iraurgi I, Zubizarreta Y, Murua F, Herrera A, Landabaso MA, Gutierrez-Fraile M. Características sociobiográficas y niveles de retención de un programa de antagonistas opiáceos en un colectivo gitano. Adicciones 1998; 10:23-31.

Iraurgi I, Jimenez-Lerma JM, Landabaso MA, Arrazola X, Gutierrez-Fraile M. Gypsies and drug addictions. Study of the adherence to treatment. Eur Addict Res 2000; 6:34-41.

Published

2005-12-01

Issue

Section

Originals